Sign In
Buy NDAQ
$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09:15am, Monday, 05'th Aug 2024
SAN DIEGO , Aug. 5, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Co
Top Wealth Group Holding Limited Announces Receipt of Nasdaq Notification Letter Regarding
07:00am, Monday, 05'th Aug 2024
Minimum Bid Price Deficiency Hong Kong, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Top Wealth Group Holding Limited (NASDAQ: TWG) (“Top Wealth” or the “Company”), a Hong Kong-based supplier of luxury c
Nasdaq Market Correction: 3 No-Brainer Stocks to Buy on the Pullback
05:42am, Monday, 05'th Aug 2024
The Nasdaq Composite Index slipped into a correction last week. Three Nasdaq stocks have especially strong growth prospects.
CNBC Daily Open: Nasdaq in correction territory; Berkshire's cash holdings reach record high
09:12pm, Sunday, 04'th Aug 2024
Nasdaq in correction territory as U.S. stocks plunge. Berkshire's cash holdings hit a record high of $276.9 billion
Meet the 5.4%-Yielding Dividend Stock That Is Crushing the S&P 500 and Nasdaq Composite in 2024
09:30am, Sunday, 04'th Aug 2024
Kinder Morgan is at a five-year high, and it still has more potential ahead. Results have been good, and the balance sheet is in excellent shape.
History Says the Nasdaq Could Soar: 3 Warren Buffett Stocks to Buy Now
07:29am, Sunday, 04'th Aug 2024
A century's worth of market history suggests investors could be looking at several more years of strong returns. Buffett's favorite stock of all time continues to look like a solid long-term investmen
2 Nasdaq Stocks to Buy Before They Soar as Much as 226% According to Select Wall Street Analysts
05:05am, Sunday, 04'th Aug 2024
Despite the index hitting multiple all-time highs this year, many veteran Wall Street analysts believe the rally has legs. Nvidia is an early beneficiary of the AI revolution and is poised to climb ev
Maquia Capital Acquisition Corporation Plans to Trade OTC After Delist from Nasdaq
06:35pm, Friday, 02'nd Aug 2024
Miami, Florida, Aug. 02, 2024 (GLOBE NEWSWIRE) -- On May 7, 2024, Maquia Capital Acquisition Corporation (“Maquia” or the “Company”) received a notice from the Listing Qualifications Departmen
Nasdaq Enters Correction As Jobs Report Fuels Massive Stock Selloff
04:42pm, Friday, 02'nd Aug 2024
All three major indexes fell Friday, as stocks declined following a report indicating the U.S. economy added fewer jobs than expected last month, kindling concerns of a recession.
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 02'nd Aug 2024
SAN FRANCISCO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, d
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Friday, 02'nd Aug 2024
WALTHAM, Mass. and DUBLIN, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies
JIADE LIMITED Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
04:05pm, Friday, 02'nd Aug 2024
Chengdu, China, Aug. 02, 2024 (GLOBE NEWSWIRE) -- JIADE LIMITED (Nasdaq: JDZG) (the “Company”), a company that specializes in providing one-stop comprehensive education supporting services to adul
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 02'nd Aug 2024
BOSTON, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on July 31, 2024, th
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Friday, 02'nd Aug 2024
CAMBRIDGE, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of July 31, 2024, the Compensation C
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Friday, 02'nd Aug 2024
NAARDEN, The Netherlands and MIAMI, Aug. 02, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutic
